Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 11, 2019

SELL
$12.68 - $19.01 $84,005 - $125,941
-6,625 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$13.1 - $16.35 $6,445 - $8,044
-492 Reduced 6.91%
6,625 $99,000
Q2 2018

Jul 13, 2018

SELL
$13.65 - $18.7 $8,435 - $11,556
-618 Reduced 7.99%
7,117 $104,000
Q1 2018

May 04, 2018

SELL
$14.85 - $24.3 $3.17 Million - $5.19 Million
-213,568 Reduced 96.5%
7,735 $123,000
Q4 2017

Feb 08, 2018

SELL
$17.4 - $23.4 $1.3 Million - $1.75 Million
-74,849 Reduced 25.27%
221,303 $4.53 Million
Q3 2017

Nov 13, 2017

BUY
$15.5 - $19.15 $19,251 - $23,784
1,242 Added 0.42%
296,152 $5.27 Million
Q2 2017

Aug 14, 2017

BUY
N/A
294,910
294,910 $5.21 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.32B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Mckinley Capital Management LLC Portfolio

Follow Mckinley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.